(Q36155438)

12 August 2017

1 reference

title

The quinolones: past, present, and future (English)

1 reference

12 August 2017

0 references

Vincent T Andriole

1

1 reference

PubMed ID

15942877

12 August 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

Clinical Infectious Diseases

12 August 2017

1 reference

12 August 2017

41 Suppl 2

1 reference

12 August 2017

S113-9

1 reference

Interactions between twisted DNAs and enzymes: the effects of superhelical turns

12 August 2017

1 reference

DNA gyrase: an enzyme that introduces superhelical turns into DNA

21 January 2018

1 reference

Nalidixic acid resistance: A second genetic character involved in DNA gyrase activity

21 January 2018

1 reference

Mechanism of action of nalidixic acid: Purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme

21 January 2018

1 reference

Purification of subunits of Escherichia coli DNA gyrase and reconstitution of enzymatic activity

21 January 2018

1 reference

Antimicrobial safety: focus on fluoroquinolones

21 January 2018

1 reference

Structure-activity and structure-side-effect relationships for the quinolone antibacterials

21 January 2018

1 reference

Fluoroquinolone antibacterials: SAR mechanism of action, resistance, and clinical aspects

21 January 2018

1 reference

DNA topoisomerase targets of the fluoroquinolones: a strategy for avoiding bacterial resistance

21 January 2018

1 reference

In vitro and in vivo antibacterial activities of a new quinolone, OPC-17116

21 January 2018

1 reference

Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from Worldwide Surveillance Studies during the 1997-1998 respiratory se

21 January 2018

1 reference

Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump

21 January 2018

1 reference

Role of TolC and parC mutation in high-level fluoroquinolone resistance in Salmonella enterica serotype Typhimurium DT204.

21 January 2018

1 reference

Monotherapy versus dual therapy for community-acquired pneumonia in hospitalized patients

21 January 2018

1 reference

Quinolone resistance among pneumococci: therapeutic and diagnostic implications

21 January 2018

1 reference

Quinolone-resistant Haemophilus influenzae in a long-term care facility: clinical and molecular epidemiology

21 January 2018

1 reference

Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia

21 January 2018

1 reference

Levofloxacin failure in a patient with pneumococcal pneumonia

21 January 2018

1 reference

Levofloxacin treatment failure in a patient with fluoroquinolone-resistant Streptococcus pneumoniae pneumonia

21 January 2018

1 reference

Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia

21 January 2018

1 reference

Fluoroquinolone-resistant Streptococcus pneumoniae associated with levofloxacin therapy

21 January 2018

1 reference

Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes?

21 January 2018

1 reference

Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens.

21 January 2018

1 reference

MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 4: Addressing the problem of poor stability due to photoisomerization of an acrylic acid moiety

21 January 2018

1 reference

The relationship between physicochemical properties, in vitro activity and pharmacokinetic profiles of analogues of diamine-containing efflux pump inhibitors

21 January 2018

1 reference

MexAB-OprM-Specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 1: Discovery and early strategies for lead optimization

21 January 2018

1 reference

Efflux pumps: their role in antibacterial drug discovery

21 January 2018

1 reference

Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus

21 January 2018

1 reference

Efflux in bacteria: what do we really know about it?

21 January 2018

1 reference

Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy

21 January 2018

1 reference

The future of the quinolones

21 January 2018

1 reference

Nalidixic acid and bacterial chromosome replication

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/428051

1 reference

12 August 2017

1 reference

PubMed ID

15942877